Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Frontiers in Immunology
|
April 2, 2025
Editorial: Spatial immunology of tissue microenvironments
Roslyn A Kemp, Felix Marsh-Wakefield
Laboratory Animal Research
|
December 9, 2020
Extensive variability in the composition of immune infiltrate in different mouse models of cancer
Virginia Niemi, Douglas Gaskarth, Roslyn A Kemp
Clinical & Translational Immunology
|
October 7, 2017
Regulatory T-cell heterogeneity and the cancer immune response
Kirsten A Ward-Hartstonge, Roslyn A Kemp
Frontiers in Medicine
|
December 11, 2025
Type I interferons in inflammatory bowel diseases: balancing barrier integrity, repair and inflammation in the intestinal epithelium
Mikayla R King, Roslyn A Kemp, Safina Gadeock
Immunology
|
June 11, 2005
The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity
Roslyn A Kemp, B Thomas Bäckström, Franca Ronchese
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V
|
May 8, 2020
Lipid-encapsulated oral therapeutic peptide vaccines reduce tumour growth in an orthotopic mouse model of colorectal cancer
Milda Naciute, Virginia Niemi, Roslyn A Kemp, et al.
Vaccine
|
August 22, 2021
Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration
Milda Naciute, Tamara Kiwitt, Roslyn A Kemp, et al.
Probiotics and Antimicrobial Proteins
|
July 20, 2021
Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12
Gemma L Laws, John D F Hale, Roslyn A Kemp
Journal of Immunological Methods
|
November 12, 2009
A defined serum-free medium useful for monitoring anti-melanoma responses induced by dendritic cell immunotherapy
Anthea L Bouwer, Petra Netter, Roslyn A Kemp, et al.
Frontiers in Immunology
|
December 21, 2016
Improved Antitumor Activity of a Therapeutic Melanoma Vaccine through the Use of the Dual COX-2/5-LO Inhibitor Licofelone
Silke Neumann, Simon A Shirley, Roslyn A Kemp, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Frontiers in Immunology
|
April 2, 2025
Editorial: Spatial immunology of tissue microenvironments
Roslyn A Kemp, Felix Marsh-Wakefield
Laboratory Animal Research
|
December 9, 2020
Extensive variability in the composition of immune infiltrate in different mouse models of cancer
Virginia Niemi, Douglas Gaskarth, Roslyn A Kemp
Clinical & Translational Immunology
|
October 7, 2017
Regulatory T-cell heterogeneity and the cancer immune response
Kirsten A Ward-Hartstonge, Roslyn A Kemp
Frontiers in Medicine
|
December 11, 2025
Type I interferons in inflammatory bowel diseases: balancing barrier integrity, repair and inflammation in the intestinal epithelium
Mikayla R King, Roslyn A Kemp, Safina Gadeock
Immunology
|
June 11, 2005
The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity
Roslyn A Kemp, B Thomas Bäckström, Franca Ronchese
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V
|
May 8, 2020
Lipid-encapsulated oral therapeutic peptide vaccines reduce tumour growth in an orthotopic mouse model of colorectal cancer
Milda Naciute, Virginia Niemi, Roslyn A Kemp, et al.
Vaccine
|
August 22, 2021
Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration
Milda Naciute, Tamara Kiwitt, Roslyn A Kemp, et al.
Probiotics and Antimicrobial Proteins
|
July 20, 2021
Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12
Gemma L Laws, John D F Hale, Roslyn A Kemp
Journal of Immunological Methods
|
November 12, 2009
A defined serum-free medium useful for monitoring anti-melanoma responses induced by dendritic cell immunotherapy
Anthea L Bouwer, Petra Netter, Roslyn A Kemp, et al.
Frontiers in Immunology
|
December 21, 2016
Improved Antitumor Activity of a Therapeutic Melanoma Vaccine through the Use of the Dual COX-2/5-LO Inhibitor Licofelone
Silke Neumann, Simon A Shirley, Roslyn A Kemp, et al.
Page
of 4